US Stock MarketDetailed Quotes

RHNMF RHINOMED LIMITED

Watchlist
  • 0.019000
  • 0.0000000.00%
15min DelayClose Feb 14 16:00 ET
5.45MMarket Cap-760P/E (TTM)

About RHINOMED LIMITED Company

Rhinomed Ltd is a medical technology company, with a patented nasal technology platform. It is engaged in the research, development and commercialization of consumer and medical devices including nasal, respiratory and nasal drug delivery technologies. It operates in one segment which is the identification, acquisition, and commercialization of late-stage consumer therapeutic and medical delivery technologies. The products of the company involve Rhinoswab, Mute, Turbine and Rhinoswab Junior. It operates geographically within North, Central, and South America, Asia-Pacific, Europe, Middle East, and Africa. The company earns majority of its revenue from Asia-Pacific.

Company Profile

SymbolRHNMF
Company NameRHINOMED LIMITED
MarketPink Market
Securities TypeOrdinary Shares
Fiscal Year Ends06-30

Company Executives

  • Name
  • Position
  • Salary
  • Michael Johnson
  • Chief Executive Officer,Executive Director
  • --
  • Ronald (Ron) Richard Dewhurst
  • Non-Executive Chairman,Non-Executive Director
  • --
  • Lynette (Lyn) Mary Swinburne
  • Non-Executive Director
  • --
  • John McBain
  • Non-Executive Director
  • --
  • Brent Scriaw
  • Non-Executive Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg